Wanbang Biopharmaceuticals

Wanbang Biopharmaceuticals


Company description

Wanbang Biopharmaceuticals Co Ltd focuses on developing, manufacturing, and selling pharmaceuticals for patients of diabetes and related cardiovascular diseases. Its products include animal insulin, Glimepiride tablets, Meglumine Adenosine Cyclophosphate, EPO, Bangtan (Telmisatan), and Heparin sodium. The company's products also comprise aloe compound capsules for clearing liver-heat, relaxing bowels, and calming heart for tranquillization; and products in the fields of chemicals, pharmaceuticals, and biotech, such as Human Interferon, Human Erythropoietin, Streptokinase, and Pemetrexed disodium. It sells products through a network of distributors and sales representatives in China and internationally. The company was founded in 1981 and is based in Xuzhou, China. Wanbang Biopharmaceuticals Co Ltd operates as a subsidiary of Shanghai FOSUN Pharmaceutical (Group) Co Ltd.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Manufacturer
Affiliated categories: Capsules More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 90G20 See our Exhibitor Profile   See full Exhibitor List
12 mar 2019

CPhI South East Asia 2019

12-14 March 2019 Bangkok, Thailand We were at stand P11 See our Exhibitor Profile   See full Exhibitor List
9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 5H10 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Wanbang Biopharmaceuticals

Wanbang Biopharmaceuticals

Contact information




View all contact information